-
The Norwegian Drug Liability Association: Mandatory Insurance for Pharmaceutical Companies
In Norway, strict regulations govern the safety and responsibility associated with the manufacturing, import, and testing of medicinal products. To ensure that patients affected by drug-related injuries receive compensation, all stakeholders in this sector are required to obtain insurance through the Norwegian Drug Liability Association (DLA). This insurance is a legal requirement under Chapter 3 of the Norwegian Product Liability Act.
-
Ensuring Pharmaceutical Quality: WHO Certificate and Apostille
In the pharmaceutical sector, it is crucial to ensure that medicinal products meet strict quality, safety, and efficacy requirements. This is not only essential for patient safety but also for obtaining approval in various markets. Two key requirements for the international distribution of pharmaceuticals are the WHO Certificate (Certificate of Pharmaceutical Product – CPP) and the apostille stamp.
